Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shobha Purushothama

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Bioanalysis|November 17, 2018
Biomarker assays: is it time for a standalone regulatory guidance?Steve Keller, Shobha Purushothama
Bioanalysis|January 16, 2014
Parallelism: considerations for the development, validation and implementation of PK and biomarker ligand-binding assaysLauren F Stevenson, Shobha Purushothama
Bioanalysis|August 14, 2013
What is going on with my samples? A general approach to parallelism assessment and data interpretation for biomarker ligand-binding assaysShawn Ciotti, Shobha Purushothama, Soma Ray
Bioanalysis|June 21, 2018
Parallelism: the foundation of biomarker assay development and validationDevangi Mehta, Shobha Purushothama, Lauren Stevenson
Journal of Pharmaceutical and Biomedical Analysis|February 26, 2020
Tissue distribution of <sup>35</sup>S-metabolically labeled neublastin (BG00010) in ratsNatalia Penner, Shobha Purushothama, Blake Pepinsky
Bioanalysis|September 14, 2017
Development of a plug and play ImmunoPCR technique for the analysis of biomoleculesSreeja Gopal, Shobha Purushothama, Alvydas Mikulskis, et al.
Journal of Immunology Research|August 25, 2016
Emerging Technologies and Generic Assays for the Detection of Anti-Drug AntibodiesMichael A Partridge, Shobha Purushothama, Chinnasamy Elango, et al.
Journal of Immunology Research|September 20, 2016
Recent Advances in Assessing Immunogenicity of Therapeutic Proteins: Impact on Biotherapeutic DevelopmentYanmei Lu, Leslie A Khawli, Shobha Purushothama, et al.
The AAPS Journal|February 6, 2020
Correction to: Recommendations for the Development of Cell-Based Anti-Viral Vector Neutralizing Antibody AssaysBoris Gorovits, Michele Fiscella, Mike Havert, et al.
The AAPS Journal|January 8, 2020
Recommendations for the Development of Cell-Based Anti-Viral Vector Neutralizing Antibody AssaysBoris Gorovits, Michele Fiscella, Mike Havert, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Bioanalysis|November 17, 2018
Biomarker assays: is it time for a standalone regulatory guidance?Steve Keller, Shobha Purushothama
Bioanalysis|January 16, 2014
Parallelism: considerations for the development, validation and implementation of PK and biomarker ligand-binding assaysLauren F Stevenson, Shobha Purushothama
Bioanalysis|August 14, 2013
What is going on with my samples? A general approach to parallelism assessment and data interpretation for biomarker ligand-binding assaysShawn Ciotti, Shobha Purushothama, Soma Ray
Bioanalysis|June 21, 2018
Parallelism: the foundation of biomarker assay development and validationDevangi Mehta, Shobha Purushothama, Lauren Stevenson
Journal of Pharmaceutical and Biomedical Analysis|February 26, 2020
Tissue distribution of <sup>35</sup>S-metabolically labeled neublastin (BG00010) in ratsNatalia Penner, Shobha Purushothama, Blake Pepinsky
Bioanalysis|September 14, 2017
Development of a plug and play ImmunoPCR technique for the analysis of biomoleculesSreeja Gopal, Shobha Purushothama, Alvydas Mikulskis, et al.
Journal of Immunology Research|August 25, 2016
Emerging Technologies and Generic Assays for the Detection of Anti-Drug AntibodiesMichael A Partridge, Shobha Purushothama, Chinnasamy Elango, et al.
Journal of Immunology Research|September 20, 2016
Recent Advances in Assessing Immunogenicity of Therapeutic Proteins: Impact on Biotherapeutic DevelopmentYanmei Lu, Leslie A Khawli, Shobha Purushothama, et al.
The AAPS Journal|February 6, 2020
Correction to: Recommendations for the Development of Cell-Based Anti-Viral Vector Neutralizing Antibody AssaysBoris Gorovits, Michele Fiscella, Mike Havert, et al.
The AAPS Journal|January 8, 2020
Recommendations for the Development of Cell-Based Anti-Viral Vector Neutralizing Antibody AssaysBoris Gorovits, Michele Fiscella, Mike Havert, et al.
Pageof 3